Mast Therapeutics Reports Update on Epic Study Enrollment, Offers '15 Milestones
January 05, 2015 at 17:18 PM EST
Mast Therapeutics, Inc. (NYSE: MSTX), a clinical-stage biopharmaceutical company, today reported that enrollment in its pivotal EPIC ...